83 related articles for article (PubMed ID: 7549841)
1. Leukocyte alkaline phosphatase score in plasma cell dyscrasias: correlation with disease severity and circulating levels of granulocyte-colony stimulating factor.
Stasi R; Bruno A; Venditti A; Del Poeta G; Coppetelli U; Tribalto M; Papa G
Leuk Lymphoma; 1995 May; 17(5-6):479-83. PubMed ID: 7549841
[TBL] [Abstract][Full Text] [Related]
2. Use of leucocyte alkaline phosphatase (LAP) score in differentiating malignant from benign paraproteinaemias.
Majumdar G; Hunt M; Singh AK
J Clin Pathol; 1991 Jul; 44(7):606-7. PubMed ID: 1713223
[TBL] [Abstract][Full Text] [Related]
3. The level of serum granulocyte colony-stimulating factor in cancer patients with leukocytosis.
Shimasaki AK; Hirata K; Kawamura T; Kunibe N; Hirai K; Yoshimoto K; Hashimoto H; Nakahara Y; Mochizuki Y
Intern Med; 1992 Jul; 31(7):861-5. PubMed ID: 1280490
[TBL] [Abstract][Full Text] [Related]
4. Serum interleukin-10 in plasma-cell dyscrasias.
Stasi R; Brunetti M; Bussa S; Pagano A
Am J Hematol; 1997 Apr; 54(4):335-7. PubMed ID: 9092693
[TBL] [Abstract][Full Text] [Related]
5. Levels of serum granulocyte colony-stimulating factor in patients with chronic myeloid leukemia.
Saitoh H; Shibata A
Leuk Lymphoma; 1993 Nov; 11(5-6):443-6. PubMed ID: 7510191
[TBL] [Abstract][Full Text] [Related]
6. Plasma cell acid phosphatase activity as prognostic factor in multiple myeloma: relationship to the thymidine-labeling index.
Boccadoro M; Gallamini A; Fruttero A; Gavarotti P; Redoglia V; Buffa F; Ruá S; Pileri A
J Clin Oncol; 1985 Nov; 3(11):1503-7. PubMed ID: 4056842
[TBL] [Abstract][Full Text] [Related]
7. A contribution to examination of propidium iodide and annexin V plasma cells indices in multiple myeloma.
Scudla V; Ordeltova M; Bacovsky J; Vytrasova M; Sumna E; Martinek A; Horak P
Neoplasma; 2003; 50(5):363-71. PubMed ID: 14628090
[TBL] [Abstract][Full Text] [Related]
8. [Granulocyte-colony stimulating factor (G-CSF) in the plasma and activity of enzymes in granulocytes of breast cancer patients].
Czygier M; Ławicki S; Szmitkowski M; Mroczko B; Omyła J
Ginekol Pol; 2004 Feb; 75(2):99-104. PubMed ID: 15108580
[TBL] [Abstract][Full Text] [Related]
9. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
Lee J; Kim Y; Lim J; Kim M; Han K
Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
[TBL] [Abstract][Full Text] [Related]
10. Flow-cytometric analysis of leukocyte alkaline phosphatase in myelodysplastic syndromes.
Okamoto T; Okada M; Yamada S; Fujimori Y; Takemoto Y; Masuhara K; Kakishita E
Acta Haematol; 1999; 102(2):89-93. PubMed ID: 10529512
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor suppresses induction of neutrophil alkaline phosphatase synthesis by granulocyte colony-stimulating factor.
Teshima T; Shibuya T; Harada M; Akashi K; Taniguchi S; Okamura T; Niho Y
Exp Hematol; 1990 May; 18(4):316-21. PubMed ID: 1691103
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activity in plasma cell dyscrasias.
Xu D; Zheng C; Bergenbrant S; Holm G; Björkholm M; Yi Q; Gruber A
Br J Cancer; 2001 Mar; 84(5):621-5. PubMed ID: 11237381
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid acts to neutralize the inhibitory effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on alkaline phosphatase activity of neutrophils that is induced by granulocyte colony-stimulating factor (G-CSF).
Mizukami H; Sato N
Exp Hematol; 1992 May; 20(4):482-5. PubMed ID: 1373689
[TBL] [Abstract][Full Text] [Related]
14. Induction of neutrophil alkaline phosphatase gene expression by granulocyte colony-stimulating factor in chronic myelogenous leukemia.
Tsushita K; Hotta T; Ichikawa A; Murate T; Saito H
Int J Hematol; 1993 Jan; 57(1):45-52. PubMed ID: 7682859
[TBL] [Abstract][Full Text] [Related]
15. Elevation in plasma alkaline phosphatase level during rhG-CSF administration. Granulocytopenic patients with gynecologic cancers treated with cancer chemotherapy.
Fukumasu H; Fukumasu Y; Ogita S
Gynecol Obstet Invest; 1998; 45(2):99-104. PubMed ID: 9517801
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
Balleari E; Bason C; Visani G; Gobbi M; Ottaviani E; Ghio R
Haematologica; 1994; 79(1):7-12. PubMed ID: 15378942
[TBL] [Abstract][Full Text] [Related]
18. Effects of granulocyte colony-stimulating factor on the kinetics of inflammatory cells in the peripheral blood and pulmonary lesions during the development of bleomycin-induced lung injury in rats.
Adachi K; Suzuki M; Sugimoto T; Uetsuka K; Nakamaya H; Doi K
Exp Toxicol Pathol; 2003 Jul; 55(1):21-32. PubMed ID: 12940625
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of the high-affinity receptor for IgG (FcRI, CD64) on neutrophils in multiple myeloma.
Ohsaka A; Saionji K; Takagi S; Igari J
Hematopathol Mol Hematol; 1996; 10(3):151-60. PubMed ID: 8878733
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte and granulocyte-macrophage colony-stimulating factors, their receptors and interleukin-3 levels in newborns.
Coşkun M; Kardelen F; Oygür N; Undar L; Savaş A; Yeğin O
Turk J Pediatr; 1997; 39(3):295-301. PubMed ID: 9339107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
